Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Colorectal Neoplasms

Free Subscription 02.11.2026 3 Ann Oncol 4 Anticancer Res 3 BMC Cancer 4 BMC Gastroenterol 1 Br J Cancer 2 Br J Surg 1 Cancer Lett 1 Clin Cancer Res 1 Dig Dis 9 Dis Colon Rectum 2 Eur J Cancer 2 Int J Cancer 2 Int J Colorectal Dis 1 J Natl Cancer Inst 1 J Pathol 1 J Surg Oncol 2 Lancet 1 Lancet Oncol 5 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Oncol

1. BENNOUNA J, Andre T, Martin E, Cremolini C, et al
   A randomised phase III trial of adjuvant treatment intensification with mFOLFIRINOX versus mFOLFOX6 in high-risk stage III colon cancer: Results of the international IROCAS study.
   Ann Oncol. 2026 Oct 25:S0923-7534(26)06886-9. doi: 10.1016/j.annonc.2026.
   PubMed         Abstract available
   
   
2. CECCHINI M, Cruz-Correa M, Han SW, Raghav K, et al
   A randomized Phase 1 study of telisotuzumab adizutecan (ABBV-400, Temab-A) in combination with bevacizumab versus trifluridine-tipiracil with bevacizumab in patients with metastatic colorectal cancer.
   Ann Oncol. 2026 Oct 24:S0923-7534(26)06887-0. doi: 10.1016/j.annonc.2026.
   PubMed         Abstract available
   
   
3. LONARDI S, Lenz HJ, Elez E, Jensen LH, et al
   Final results of nivolumab plus ipilimumab versus nivolumab or chemotherapy in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer from CheckMate 8HW.
   Ann Oncol. 2026 Oct 24:S0923-7534(26)06652-4. doi: 10.1016/j.annonc.2026.
   PubMed         Abstract available
   
   

   
   Anticancer Res

4. RYU S, Imaizumi Y, Nakashima S, Kawakubo H, et al
   Association of Institution-wide Fluorescent Ureteral Navigation Implementation With Minimally Invasive Surgery Completion in Rectal Cancer.
   Anticancer Res. 2026;46:6203-6217.
   PubMed         Abstract available
   
   
5. OMAMEUDA T, Miki A, Sakuma Y, Yamaguchi H, et al
   Preoperative Albumin-derived Neutrophil-to-Lymphocyte Ratio Predicts Survival Across Pathological Stages of Colorectal Cancer.
   Anticancer Res. 2026;46:6417-6425.
   PubMed         Abstract available
   
   
6. SHIRAISHI T, Osone K, Hasegawa M, Katayama C, et al
   Clinical Outcomes of Preoperative Hyperthermic Chemoradiotherapy for Locally Advanced Rectal Cancer.
   Anticancer Res. 2026;46:6393-6407.
   PubMed         Abstract available
   
   
7. SHIRAISHI T, Tominaga T, Wakata K, Nishimuta M, et al
   Feasibility and Short-term Outcomes of Robotic Surgery for Transverse Colon Cancer: A Multicenter Retrospective Study.
   Anticancer Res. 2026;46:6427-6435.
   PubMed         Abstract available
   
   

   
   BMC Cancer

8. KOSGALLANA W, Wijetunge S, Malaviarachchi S, Prathapan S, et al
   A novel predictive model for DNA mismatch repair deficient colorectal carcinoma for cost-effective MMR testing in low-resource settings: HERALD-MMR (Histological Evaluation and Risk Assessment using Local Demographics for Mismatch Repair).
   BMC Cancer. 2026;26:1321.
   PubMed         Abstract available
   
   
9. BANG K, Jeong D, Hong S, Koh HK, et al
   Early-onset colorectal cancer in Korea: clinical characteristics, treatment patterns, and survival outcomes in a K-CURE nationwide population-based study.
   BMC Cancer. 2026;26:1305.
   PubMed         Abstract available
   
   
10. HUANG C, Feng S, Yi H, Tao W, et al
    ZNF556 serves as an immunological and prognostic biomarker in colon adenocacinoma.
    BMC Cancer. 2026;26:1295.
    PubMed         Abstract available
    
    

    
    BMC Gastroenterol

11. IMPERIALE TF, Godfrey M, Thomas MR, Sheel V, et al
    Yield and efficiency of fecal immunochemical tests (FITs) for advanced colorectal neoplasia alone vs. with risk factors or risk prediction models: a descriptive systematic review.
    BMC Gastroenterol. 2026;26:701.
    PubMed         Abstract available
    
    
12. SAHIN K, Colak T, Guler E, Ozcan C, et al
    Functional outcomes and quality of life after low anterior resection for rectal cancer: a retrospective cohort study comparing coloanal and colorectal anastomosis.
    BMC Gastroenterol. 2026;26:700.
    PubMed         Abstract available
    
    
13. ZHANG Z, Chen J, Ma Y, Wang W, et al
    Prognostic value of Gli1 expression on colorectal cancer: a retrospective study.
    BMC Gastroenterol. 2026;26:715.
    PubMed         Abstract available
    
    
14. WU J, Li Z, Ai L, Huang A, et al
    Methylation-sensitive restriction endonuclease-based amplification assay for detecting DNA methylation in colorectal cancer: a cross-sectional study.
    BMC Gastroenterol. 2026;26:713.
    PubMed         Abstract available
    
    

    
    Br J Cancer

15. CHOE EK, Kim MJ, Lee DW, Park SC, et al
    Complete blood count-derived inflammation indices in colorectal cancer: head-to-head case-control and prognostic analyses with population reference intervals and external replication.
    Br J Cancer. 2026 Oct 24. doi: 10.1038/s41416-026-03647.
    PubMed         Abstract available
    
    

    
    Br J Surg

16. MARCHEGIANI F, Dhote A, Nassar A, Mallet V, et al
    Combined versus staged resection of synchronous rectal cancer liver metastases: national target trial emulation.
    Br J Surg. 2026;113:znag121.
    PubMed         Abstract available
    
    
17. SONG SH, Min BS, Park JS, Lee KY, et al
    Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision for rectal cancer: COLRAR randomized clinical trial.
    Br J Surg. 2026;113:znag114.
    PubMed         Abstract available
    
    

    
    Cancer Lett

18. SONG L, Yan T, Lu SY, Tong T, et al
    SPP1(+) TAMs drive colorectal tumorigenesis through an ARG2-orchestrated metabolic-immune crosstalk.
    Cancer Lett. 2026;661:218890.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

19. SRIKUMAR T, Sundar R
    An Act of DeFianCe: Targeting DKK1 in Metastatic Colorectal Cancer.
    Clin Cancer Res. 2026 Oct 30. doi: 10.1158/1078-0432.CCR-26-2653.
    PubMed         Abstract available
    
    

    
    Dig Dis

20. CHOI HH, Seo KJ, Kim SW, Kim HK, et al
    Trembling Technique for Improving Colonic Adenoma Detection Rate by Enhancing Mucosal Exposure during Withdrawal: A Prospective, Non-Randomized Single-Center Study.
    Dig Dis. 2026;44:482-490.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

21. SHEN Y, Lu A, Jiang T, Zhang Z, et al
    Predictive Value of Endoscopy in the Identification of Complete Response After Neoadjuvant Therapy for Rectal Adenocarcinoma.
    Dis Colon Rectum. 2026;69:2714-2723.
    PubMed         Abstract available
    
    
22. LI Y, Shi Y, Jiang B, Wang G, et al
    Comparative Outcomes of Natural Orifice Specimen Extraction Surgery, Laparoscopic Surgery, and Open Surgery for Rectal Cancer: A Multicenter Propensity-Weighted Study.
    Dis Colon Rectum. 2026;69:2694-2703.
    PubMed         Abstract available
    
    
23. GAO C, Li S, Wang T, Zhang Z, et al
    A Systematic 3-Step Posterior Sacral Resection for High Sacrectomy (S2 and Below) in Pelvic Malignancies.
    Dis Colon Rectum. 2026;69:2649-2657.
    PubMed         Abstract available
    
    
24. LIU B, Zhuo L, Wang Y, Luo H, et al
    Building Machine Learning Models Based on Oxidative Stress Index Score to Predict Survival of Locally Advanced Rectal Cancer Receiving Different Neoadjuvant Therapy Patterns.
    Dis Colon Rectum. 2026;69:2658-2672.
    PubMed         Abstract available
    
    
25. SZEGLIN B, Consul MS, Breckheimer MC, Whitbread JJ Jr, et al
    Short- Versus Long-Course Radiation in Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Propensity-Matched National Cancer Database Analysis.
    Dis Colon Rectum. 2026;69:2639-2648.
    PubMed         Abstract available
    
    
26. BIDEWELL M, Bhattacharya P, Ezeme C, Perin G, et al
    Comment on "A mutation-specific Decision Model for Segmental Versus Total Abdominal Colectomy in Hereditary Nonpolyposis Colorectal Cancer".
    Dis Colon Rectum. 2026 Oct 26. doi: 10.1097/DCR.0000000000004510.
    PubMed        
    
    
27. FLEMING FJ, Li Y
    Revisiting an Old Question: Volume and Outcomes after Colorectal Cancer Surgery.
    Dis Colon Rectum. 2026 Oct 26. doi: 10.1097/DCR.0000000000004508.
    PubMed        
    
    
28. LI H, Cai Y, Wang Y, Yi C, et al
    Electroacupuncture for Postoperative Gastrointestinal Recovery After Laparoscopic Colorectal Cancer Resection: A Randomized Controlled Trial Electroacupuncture Fastens Recovery: Retraction.
    Dis Colon Rectum. 2026;69:2783.
    PubMed        
    
    
29. ZERHOUNI Y, Donahue C, Kelly M, Theodoropoulos G, et al
    Management, Survivorship, and Supportive Care in Early-Onset Colorectal Cancer.
    Dis Colon Rectum. 2026 Oct 26. doi: 10.1097/DCR.0000000000004500.
    PubMed        
    
    

    
    Eur J Cancer

30. WEBER K, Voelkl A, Heinemann V, Boeck S, et al
    Multimodal treatment of isolated leptomeningeal relapse in BRAF-mutated dMMR colon cancer.
    Eur J Cancer. 2026;249:117795.
    PubMed        
    
    
31. CHANG J, Li Y, Mo S, Chen Z, et al
    Circulating tumor DNA-guided therapeutic strategies for metastatic colorectal cancer patients with multiple small pulmonary-limited nodules: A prospective cohort study.
    Eur J Cancer. 2026;249:117793.
    PubMed         Abstract available
    
    

    
    Int J Cancer

32. LOFT M, Gibbs P
    Reply to: Comments on 'Concomitant Use of Proton Pump Inhibitors and Survival Outcomes in Patients Receiving Adjuvant Chemotherapy for Stage III Colon Cancer'.
    Int J Cancer. 2026 Oct 25. doi: 10.1002/ijc.70793.
    PubMed        
    
    
33. ZHANG X, Zhang Y
    Comments on "Concomitant Use of Proton Pump Inhibitors and Survival Outcomes in Patients Receiving Adjuvant Chemotherapy for Stage III Colon Cancer".
    Int J Cancer. 2026 Oct 25. doi: 10.1002/ijc.70794.
    PubMed        
    
    

    
    Int J Colorectal Dis

34. WATANABE D, Fujii H, Miura Y, Kani M, et al
    Proteinuria with extended VEGF inhibitor therapy in RAS-mutant metastatic colorectal cancer: incidence, interruptions, and exploratory survival analysis.
    Int J Colorectal Dis. 2026;41:175.
    PubMed         Abstract available
    
    
35. OTA E, Ozawa M, Nakagawa K, Suwa H, et al
    A comparison of extended right hemicolectomy and transverse colectomy with D3 lymph node dissection for pathological stage II/III advanced mid-transverse colon cancer.
    Int J Colorectal Dis. 2026;41:171.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

36. REEDER-HAYES KE, Jackson BE, Lund J, Kuo TM, et al
    Statewide surveillance of colorectal cancer screening using geospatial and Multi-Payer claims data.
    J Natl Cancer Inst. 2026 Oct 29:djag407. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Pathol

37. LIANG Y, Deng X, Wang T, Chang X, et al
    Integrative single-cell transcriptomic and metabolic profiling reveals lactate-driven glycolytic reprogramming and histone lactylation in colorectal cancer liver metastasis.
    J Pathol. 2026 Oct 27. doi: 10.1002/path.70138.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

38. OLSON KA, Maniskas SA, Marty M, Labadie K, et al
    Retroperitoneal and Lateral Pelvic Lymph Node Dissection for Colorectal Cancer Metastases.
    J Surg Oncol. 2026 Oct 29. doi: 10.1002/jso.70443.
    PubMed         Abstract available
    
    

    
    Lancet

39. CIRACI P, Cremolini C
    Optimising late-line treatment administration in metastatic colorectal cancer: an even brighter SUNLIGHT.
    Lancet. 2026 Oct 24:S0140-6736(26)02034-9. doi: 10.1016/S0140-6736(26)02034.
    PubMed        
    
    
40. SAKAKIDA T, Taniguchi H, Asayama M, Suwa Y, et al
    14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.
    Lancet. 2026 Oct 24:S0140-6736(26)01782-4. doi: 10.1016/S0140-6736(26)01782.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

41. TAO K, Lin Z, Zhang P, Chi P, et al
    Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.
    Lancet Oncol. 2026;27:1437-1449.
    PubMed         Abstract available
    
    

    
    PLoS One

42. SCHOENAKER IJH, Brohet RM, Finnema EJ, Damminga DC, et al
    Detection of potentially curable recurrence after colorectal cancer surgery in a real-world population.
    PLoS One. 2026;21:e0361933.
    PubMed         Abstract available
    
    
43. WU X, Situ W, Feng Z, Yang H, et al
    Investigating the potential association between the continuous-time random-walk MR diffusion model and lymph node metastasis and vascular invasion in patients with rectal cancer: A preliminary exploratory study.
    PLoS One. 2026;21:e0361487.
    PubMed         Abstract available
    
    
44. DUAN Z, Wu F
    Experiences of self-management behaviors during adaptation to permanent enterostomy among older patients: A qualitative study.
    PLoS One. 2026;21:e0360643.
    PubMed         Abstract available
    
    
45. ABRAHA TG, Terefe MR, Asfaw ZG
    Survival modeling and assessing prognostic factors of colorectal cancer in Ethiopia: Addressing violation of statistical assumptions.
    PLoS One. 2026;21:e0361233.
    PubMed         Abstract available
    
    
46. AL-KABARITI AY, Abbas MA, Alashhab M, Smarakan S, et al
    Claudin-18 expression is associated with poorer overall survival in colorectal cancer.
    PLoS One. 2026;21:e0360740.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum